Retirement village residents are among those taking part in a world-first Australian study exploring whether the fabled Mediterranean Diet - combined with exercise - can stave off dementia and slow older age.
The mediterranean diet is high in fruit, vegetables, legumes, whole grains and fish, while being low in saturated fats, red meat, and alcohol.
Researchers at the University of South Australia and Swinburne University, along with a consortium of partners will explore the health benefits of older people adhering to a Mediterranean diet, while also undertaking daily walking.
Termed the MedWalk Trial, the two-year, $1.8 million study will recruit 364 older Australians – aged 60-90 years and without cognitive impairment – across 28 residential sites in South Australia and Victoria.
It’s a timely study, particularly given Australia’s ageing population, where around a quarter of all Australians will be aged 65+ by 2050.
Lead UniSA researcher, Associate Professor Karen Murphy, says combining the dietary benefits of the Mediterranean Diet with the health benefits of an exercise intervention could deliver significant benefits.
“Dementia is a condition that affects a person’s thinking, behaviour and ability to perform everyday tasks. While it is more common in older Australians, it’s not a normal part of ageing,” Assoc Prof Murphy says.
“In Australia, around 472,000 people are living with dementia. Each year it costs the economy more than $14 billion which is expected to balloon to more than $1 trillion over the next 40 years.
“While there is currently no prevention or cure for dementia, there is growing consensus that a focus on risk reduction can have positive outcomes. That’s where our study comes in.
Early pilots of our MedWalk intervention show improved memory and thinking in a sub-group of older participants adhering to a combination of Mediterranean diet and daily walking for six months.
“We’re now extending this study across a broader group of older Australians, using carefully-designed behavioural change and maintenance strategies in the hope of substantially reducing the incidence of dementia across Australia.”
The 24-month study will randomly assign residential community sites the MedWalk intervention, or their usual lifestyle (the control group), so that all participants who live at one facility will be in the same group.
Changes to diet and walking will be supported through organised and regular motivational, dietary and exercise sessions.
Head of Neurocognitive Ageing Research at Swinburne’s Centre for Human Psychopharmacology and Chief Investigator, Professor Andrew Pipingas, says this trial is about trying to prevent the onset of dementia.
As it’s extremely difficult to find a cure and treat those in the later stages of the disease, focusing our efforts on helping those at risk of developing dementia to stay healthy is one-way to ensure Australians stay well in future,” he said.
For more information about joining the study, please contact: 08 8302 1417 or email [email protected]
